![Kazuo Tsubota](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kazuo Tsubota
Oprichter bij TSUBOTA LABORATORY INCORPORATED
Vermogen: 36 M $ op 31-05-2024
Oorsprong van het eerstegraads netwerk van Kazuo Tsubota
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Public Company | Miscellaneous Commercial Services | 4 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Kazuo Tsubota via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
RAQUALIA PHARMA INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Tokyo Institute of Technology | College/University | Doctorate Degree | |
AskAt, Inc.
![]() AskAt, Inc. Pharmaceuticals: MajorHealth Technology AskAt, Inc. was founded in 2013 and is committed to optimizing the drug discovery process to deliver groundbreaking medications for pain, cancer, and dementia to patients worldwide. The company is based in Nagoya, Japan. The Japanese company's portfolio includes a focus on pain, cancer, and dementia, and their corporate philosophy and vision are centered around delivering innovative solutions to improve patient outcomes. AskAt was acquired by AskAat, Inc. /Yoshida/ from RaQualia Pharma, Inc. on May 14, 2015. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer |
Statistieken
Internationaal
Japan | 4 |
Sectoraal
Health Technology | 3 |
Consumer Services | 2 |
Operationeel
Director/Board Member | 5 |
Chief Tech/Sci/R&D Officer | 3 |
Corporate Officer/Principal | 3 |
Chief Administrative Officer | 2 |
Doctorate Degree | 1 |
Sterkste connecties
Insiders | |
---|---|
Shinichi Koizumi | 4 |
Shintaro Yamada | 1 |
Shinichiro Kondo | 1 |
Takanari Shimizu | 1 |
- Beurs
- Insiders
- Kazuo Tsubota
- Bedrijfsconnecties